Everyone is curious about what health utilization and spending by the exchange enrollees will look like and how that will compare to pricing. We have gotten some answers to that question just watching insurer behavior, as some low-priced plans have dropped out for 2015 and others have raised prices significantly. The fastest information is generally from drug use, which is captured electronically in real-time for virtually 100% of prescriptions. Express Scripts recently issued a follow-on report describing the drug use of exchange enrollees in its data base. (ES Report) Nearly 50% of enrollees in an exchange plan used their pharmacy benefit, compared to 55% in other private plans. They had a generic drug use rate of 87%, which is higher than the 82% rate for other privately-insured persons. In general, exchange members are covered by plans with relatively high cost-sharing, which provides an incentive for selecting cost-effective compounds. Those persons who signed up late in the open enrollment period tended to be younger, poorer and use less medications than the exchange population overall. They were also healthier, with lower rates of common chronic diseases. Exchange enrollees were using a lot of specialty drugs, probably the effect of adverse selection, whereby persons with more serious illnesses were more likely to get insurance to cover the costs of treating those diseases. Specialty drugs, which are very expensive, were 59% more likely to be taken by exchange members than the traditional insured population. Almost 60% of all prescriptions filled by this group were for HIV. This suggests that managing specialty drug costs may be particularly important for insurers offering exchange plans. And the general trend of higher drug use in these categories not only suggests higher overall drug spending, but there is usually significant other health spending associated with these diseases. If exchange enrollment continues to lag and be a small percent of the uninsured, or, as is possible, if some of the healthier exchange enrollees decide to drop out, it is likely that premiums for exchange plans will begin to increase rapidly.
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.
Healthy Skeptic Podcast
Research
MedPAC 2019 Report to Congress
June 18, 2019
Headlines
Tags
Access
ACO
Care Management
Chronic Disease
Comparative Effectiveness
Consumer Directed Health
Consumers
Devices
Disease Management
Drugs
EHRs
Elder Care
End-of-Life Care
FDA
Financings
Genomics
Government
Health Care Costs
Health Care Quality
Health Care Reform
Health Insurance
Health Insurance Exchange
HIT
HomeCare
Hospital
Hospital Readmissions
Legislation
M&A
Malpractice
Meaningful Use
Medicaid
Medical Care
Medicare
Medicare Advantage
Mobile
Pay For Performance
Pharmaceutical
Physicians
Providers
Regulation
Repealing Reform
Telehealth
Telemedicine
Wellness and Prevention
Workplace
Related Posts
Commentary
How to Waste an Election
November 6, 2024
How to Waste an Election
The new administration has to show determination to eliminate the deficit and begin reducing our…
Commentary
Credit Where Credit Is Due
November 6, 2024
Credit Where Credit Is Due
It has been an amazing campaign and Trump deserves all the credit for his perseverance.
Commentary
No Time for Gloating, Well, Maybe in One Respect its Okay
November 6, 2024
No Time for Gloating, Well, Maybe in One Respect its Okay
If you have come to despise Little Timmy, as I have, revel in his humiliation…